Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-995-1 | CAS number: 93841-25-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
- Objective of study:
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The aim of the study was to investigate the percutaneous absorption under approximately realistic conditions using two different formulations and a test substance solution, the distribution into the organs 72 hours after application, the mode and rate of elimination. 14C labelled test substance was used in order to simplify the analysis.
- GLP compliance:
- yes
Test material
- Reference substance name:
- 3-(2-hydroxyethyl)-p-phenylenediammonium sulphate
- EC Number:
- 298-995-1
- EC Name:
- 3-(2-hydroxyethyl)-p-phenylenediammonium sulphate
- Cas Number:
- 93841-25-9
- Molecular formula:
- C8H12N2O.H2O4S
- IUPAC Name:
- 2-(2,5-Diaminophenyl)ethanol sulfate (1:1)
Constituent 1
- Specific details on test material used for the study:
- Test substance : 2-(2,5-Diaminophenyl)ethanol sulphate
Other name : Betoxol
Radioactive test substance : Ring-14C (synthesis by Amersham, England)
Radiochemical purity : 97% - Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- other: dermal (3 experiments), oral (2 experiments)
- Vehicle:
- other: two different hair dyeing formulations (dermal), water (oral)
- Details on exposure:
- Cutaneous application (experiment A, B, C) : Application occurred once for 30 minutes to the dorsal, median thoracic to lumbar area. The dorsal skin of the animals was clipped one day before application of the test substance using an electric hair clipper (1mm cutterhead). Anaesthesia : 40mg thiopental i.p. per kg bw before administration of the formulations and the solution. Application of the formulations : Spreading evenly until the skin was wetted with a spatula to an area of 3cm x 3cm. Determination of the actual mass applied was by weighing. Application of the solution : The solution was applied and spread evenly until the skin was wetted using a plastic syringe. Rinsing : The formulation or the solution was left for 30 min then scraped off using a spatula followed by rinsing until the rinsing water and the absorbent tissue which was used to dab the skin dry were free of colour. The treated area was covered with 4 layers of gauze fixed by adhesive tape.
Oral application : Sixteen hours before application the rats were deprived of feed and the test substance solution applied by gavage. The actual mass administered was determined by weighing. - Duration and frequency of treatment / exposure:
- Seventy two hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1.63 other: mg/cm2
- Remarks:
- experiment A
- Dose / conc.:
- 1.63 other: mg/cm2
- Remarks:
- experiment B
- Dose / conc.:
- 1.67 other: mg/cm2
- Remarks:
- experiment C
- Dose / conc.:
- 15.1 other: mg/kg bw
- Remarks:
- experiment D
- Dose / conc.:
- 15.9 other: mg/kg bw
- Remarks:
- experiment E
- No. of animals per sex per dose / concentration:
- Three females and three males were used in each of the five experiments (A-E).
- Control animals:
- other: oral application of the test substance was used as a reference
- Details on study design:
- The test substance is a constituent of hair dyeing products. The aim of the study was to investigate the percutaneous absorption under approximately realistic conditions using two different formulations and a test substance solution, the distribution into the organs 72 hours after application, the mode and rate of elimination.
- Details on dosing and sampling:
- Six samples of each formulation and solutions of the test substance were taken to check the homogeneity and also to determine the specific radioactivity.
Application site washings (rinsings) ie combined samples of scraped off formulations dissolved in methanol/water, solution of shampoo, rinsing water, methanol/water extracts of the absorbent tissue used for drying skin.
Blood samples.
Urine and faeces : Daily collection from the metabolism cages.
The animals were killed after 72 hours (experiments A, B, C, D) and 24 hours (experiment E).
Post mortem organs taken : Adrenals, blood, brain, fat, femur, heart, kidneys, liver, lungs, muscle, ovaries, skin (untreated).
Results and discussion
Any other information on results incl. tables
The mean percutaneous absorptions of the test substance were very low in each of the three experiments. (0.063% for hair dyeing formulation I, 0.077% for hair dyeing formulation II plus hydrogen peroxide, 0.124% for the test substance solution). The 14C labelled compound was excreted to a larger extent via urine (75-86% of the eliminated 14C) and to a lesser extent via faeces (14-25%). The mean excretion within the first 24 hours was fast (87-95% of the eliminated 14C in experiments A to C). Mean 14C concentrations of blood and the 14 analysed organs in experiments A to C were all near or below the detection limit after 72 hours. After oral administration of the test substance the 14C labelled compound was excreted to a larger extent via urine (86% of the eliminated 14C) and to a lesser extent via faeces (14%). The 14C compound excreted within the first 24 hours equated to 99%. Highest 14C cncentrations were detected in the thyroid, liver and adrenals. Lowest detected in testes, fat, femur. The blood level was highest after 35 minutes post administration and declined with an initial half-life of ~50 minutes.
Applicant's summary and conclusion
- Conclusions:
- The mean percutaneous absorptions of the test substance were low in each of three experiments (0.063% for hair dyeing formulation I, 0.077% for hair dyeing formulation II plus hydrogen peroxide, 0.124% for the test substance solution). The 14C labelled compound was excreted to a larger extent via urine (75-86% of the eliminated 14C) and to a lesser extent via faeces (14-25%). The mean excretion within the first 24 hours was fast (87-95% of the eliminated 14C in experiments A to C). After oral administration of the test substance the 14C labelled compound was excreted to a larger extent via urine (86% of the eliminated 14C) and to a lesser extent via faeces (14%). The 14C compound excreted within the first 24 hours equated to 99%.
- Executive summary:
14C labelled 2,5 -diaminophenylethanol sulphate was applied to the dorsal skin of rats for 30 minutes then washed off. The test substance was integrated into two different hair dyeing formulations (I and II) or was evaluated as a solution in water. Hair dyeing formulation II was mixed with Welloxon (containing 9% hydrogen peroxide) before application. Oral application of the test substance was used as a reference. An additional experiment was performed to determine the blood level after peroral application.
Experiment Characteristics Samples drawn Duration A cutaneous application formulation I rinsing water, treated skin, urine, faeces, organs, carcass 72 hours B cutaneous application formulation II + Welloxon rinsing water, treated skin, urine, faeces, organs, carcass 72 hours C cutaneous application solution of test item rinsing water, treated skin, urine, faeces, organs, carcass 72 hours D oral application solution of test item urine, faeces, organs, carcass without GIT 72 hours E oral application solution of test substance blood 24 hours The mean percutaneous absorptions of the test substance were very low in each of the three experiments. (0.063% for hair dyeing formulation I, 0.077% for hair dyeing formulation II plus hydrogen peroxide, 0.124% for the test substance solution). The 14C labelled compound was excreted to a larger extent via urine (75-86% of the eliminated 14C) and to a lesser extent via faeces (14-25%). The mean excretion within the first 24 hours was fast (87-95% of the eliminated 14C in experiments A to C). Mean 14C concentrations of blood and the 14 analysed organs in experiments A to C were all near or below the detection limit after 72 hours. After oral administration of the test substance the 14C labelled compound was excreted to a larger extent via urine (86% of the eliminated 14C) and to a lesser extent via faeces (14%). The 14C compound excreted within the first 24 hours equated to 99%. Highest 14C cncentrations were detected in the thyroid, liver and adrenals. Lowest detected in testes, fat, femur. The blood level was highest after 35 minutes post administration and declined with an initial half-life of ~50 minutes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)